BRANDON GUTH: Open Payments
NPI 1629587282 · RICHMOND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,456 in 209 payments from 23 companies in 2025. Trend: 2023 $1,131 · 2024 $3,447 · 2025 $5,456
Food & beverage: $2,896Speaker / faculty: $2,500Education: $59
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 77 | $3,584 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 27 | $367 |
| Novo Nordisk Inc | 12 | $165 |
| Lundbeck LLC | 16 | $156 |
| Vanda Pharmaceuticals Inc. | 14 | $141 |
| Abbott Laboratories | 6 | $104 |
| AstraZeneca Pharmaceuticals LP | 6 | $95 |
| Astellas Pharma US Inc | 4 | $89 |
| Amgen Inc. | 5 | $87 |
| Lilly USA, LLC | 5 | $86 |
Products named: VRAYLAR, CAPLYTA, REXULTI, FANAPT, QULIPTA, Veozah, MOUNJARO, FREESTYLE LIBRE 3.
Industry payments across IN — which companies pay providers there.
